Medistep Healthcare

Medistep Healthcare Limited - IPO

SME

Medistep Healthcare IPO Details

Open Date
08 Aug 2025
Close Date
12 Aug 2025
Listing Date
18 Aug 2025
Issue Price
₹43 - ₹43
Face Value
₹10 per share
Lot Size
3000
GMP
₹13 (30.2%)
Issue Type
IPO
Listing On
NSE
Type
Fixed Price Issue
Share holding pre issue
10465546
Share holding post issue
14209546
Total Issue Size
37,44,000 shares (aggregating up to ₹16.10 Cr)
Fresh Issue
37,44,000 shares (aggregating up to ₹16.10 Cr)
Offer for Sale
-

Medistep Healthcare IPO Subscription

Medistep Healthcare IPO Application Wise Breakup

Medistep Healthcare IPO Dates

  • 08 Aug 2025
    Opening dateOPD
  • 12 Aug 2025
    Closing dateCOD
  • 13 Aug 2025
    Basis of AllotmentBOA
  • 14 Aug 2025
    Initiation of RefundsIOR
  • 14 Aug 2025
    Credit of SharesCOS
  • 18 Aug 2025
    Listing dateLID

Medistep Healthcare IPO Lot Size

ApplicationLotsSharesAmount
Individual Minimum26000₹258,000
Individual Maximum26000₹258,000
HNI Minimum39000₹387,000

Medistep Healthcare IPO Reservation

Promoter Holding

Pre Issue:93.62%
Post Issue:68.96%
Promoter Names:
Girdhari Lal Prajapat, Dabhi Vipul Gobarbhai, Prajapati Hetalben Girdharilal

Medistep Healthcare IPO Valuations

ROE:44.44%
ROCE:59.10%
RONW:44.44%
PAT MARGIN:8.52%

Medistep Healthcare Limited Financial Information

Period Ended30 Jun 202431 Mar 202431 Mar 202331 Mar 2022
Assets24.0214.9614.667.1
Total Income11.2531.6327.747.62
Profit After Tax1.022.910.920.19
Net Worth13.7111.691.070.33
Reserves and Surplus3.256.79
Amount in ₹ Crore

About Medistep Healthcare IPO

Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products. They are committed to quality and seek to expand their product line as a public, non-government company.

The product includes the followings:-

  • Sanitary Pads: Medistep produces high-quality sanitary pads, addressing essential feminine hygiene needs.
  • Energy Powder: The company manufactures energy supplements designed to revitalize and invigorate consumers.
  • Pharmaceutical Products: Medistep engages in the trading of various pharmaceutical items, ensuring accessibility to essential medications.
  • Nutraceutical Products: They offer products that blend nutrition and pharmaceuticals, promoting overall health and wellness.
  • Intimate Care and Hygiene Products: The company provides personal hygiene and intimate care products.
  • Surgical Products: Medistep supplies surgical items and supports medical professionals with necessary tools and equipment.

As of December 30, 2024, Medistep reported annualized revenues of ₹45.00 crore and a Profit After Tax (PAT) of ₹4.08 crore.

As of December 28, 2024, the company has nine employees on payroll. Labour needs depend on daily-paid labourers, and none are on contract.

 

Strength Of Medistep Healthcare IPO

1. Experienced Promoters and Senior Management with extensive domain knowledge.

2. Quality assurance and control.

3. Market Potential.

4. Investment in latest technology and maintain our edge in the market.

Risk Of Medistep Healthcare IPO

1. The company provide its goods majorly in Gujarat, any adverse changes in the conditions affecting these regions can adversely affect its business, financial condition and results of operations.

2. The company manufacturing facility are subject to operational risks. Any slowdown or shutdown in its manufacturing operations could adversely affect the company business, financial condition and results of operations.

3. The company relies on domestic third-party suppliers for the supply of raw materials and any delay, interruption or reduction in such supply could adversely affect its business, results of operations, financial condition and cash flows.

4. The company is subject to extensive government regulations and if its fail to obtain, maintain or renew the company statutory and regulatory licenses, permits and approvals required to operate its business, the company business, financial condition, results of operations and cash flows may be adversely affected.

5. The Company is dependent on few numbers of customers for sales. The loss of any of this large customer may affect its revenues and profitability.

6. Any increase in the cost of its raw material or other purchases or a shortfall in the supply of the company raw materials, may adversely affect the pricing and supply of its products and have an adverse effect on the company business, results of operations and financial condition.

7. If the company is unable to patent new processes, obtain trademarks for its products, or protect such proprietary information, the company business may be adversely affected.

8. The company inability to accurately forecast demand for its products and manage the company inventory may have an adverse effect on its business, financial condition, results of operations and cash flows.

9. The company has had negative cash flows from investing activities during the Financial Year 2024. Negative cash flows over extended periods, or significant negative cash flows in the short term, could affect its ability to operate the company business and implement its growth plans.

10. The company requires working capital for its smooth day-to-day operations of business and any discontinuance or its inability to acquire adequate working capital timely and on favourable terms may have an adverse effect on its operations, profitability and growth prospects.

Objectives Medistep Healthcare IPO

1. Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility

2. Working Capital requirements

3. General Corporate Purpose

Company Contact Details

Medistep Healthcare Ltd.
05, S. No-245/B, Plot-19, T.P.S. 56,
Free Way Trade Center, Nr.A-One Hotel N.H.-8
Narol Gam, Narol Daskroi,
Ahmedabad, Gujarat, 382405
Phone: +91 87808 46963
Email: Info@medistephc.com
Website: https://www.medistephc.com/

Registrar Contact Details

Name: Cameo Corporate Services Limited
Phone: +91-44-28460390

Comments